SCHEMBL3860068

SCHEMBL3860068

CC(C)(C)OC(=O)NCCC(O)c1cccc(CC#CCO)c1

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.39
NQO2 P16083 1/20 0.38
CTSS P25774 8/20 0.37
CTSK P43235 6/20 0.37
CTSB P07858 4/20 0.37
MALT1 Q9UDY8 1/20 0.36
MEN1 O00255 1/20 0.36
GAA P10253 1/20 0.36
KMT2A Q03164 1/20 0.36
CTSL P07711 3/20 0.36
SIGMAR1 Q99720 2/20 0.36
POLB P06746 1/20 0.36
KDM4E B2RXH2 1/20 0.36
SYK P43405 1/20 0.35
KCNA5 P22460 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL612632 0.86 DDB1 (0.43) IDO1NQO2CTSSCTSKMALT1
SCHEMBL238012 0.83 PTGES (0.43) IDO1CTSSCTSKCTSBMALT1
SCHEMBL613498 0.83 TDP1 (0.45) IDO1NQO2CTSSCTSKMALT1
SCHEMBL614479 0.82 CTSK (0.47) IDO1NQO2CTSSCTSKCTSB
SCHEMBL10318009 0.81 KDM4E (0.46) IDO1NQO2MALT1MEN1GAA
SCHEMBL235309 0.80 DDB1 (0.41) NQO2CTSSCTSKMALT1MEN1
SCHEMBL613522 0.80 NQO2 (0.43) IDO1NQO2CTSSCTSKMALT1
SCHEMBL17735443 0.79 POLB (0.45) IDO1NQO2CTSSCTSKMALT1
SCHEMBL16079975 0.79 POLB (0.45) IDO1NQO2CTSSCTSKMALT1
SCHEMBL16031480 0.79 NQO2 (0.51) IDO1NQO2CTSSCTSKMALT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2076122-A2 ALKYNYL PHENYL DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS Acucela, Inc. (US) 2009-07-08 EP disclosed
WO-2009005794-A2 ALKYNYL PHENYL DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS ACUCELA, INC. (US) 2009-01-08 WO disclosed